Real-time enrollment status for this primary cns lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:13 PM UTC
| NCT Number | NCT04656431 |
| Recruiting Status | Recruiting |
| Condition | Primary CNS Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 1 sites in the US |
| Sponsor | James Rubenstein |
| Last Updated on CT.gov | July 14, 2026 (4 days ago) |
As of July 18, 2026: Clinical trial NCT04656431 is currently recruiting participants. This phase1 study for primary cns lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by James Rubenstein. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04656431 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04656431 was last updated 4 days ago (July 14, 2026). HelloStudys verifies this status automatically.